Indeed, recent studies in animal models suggest that MAO-A/B activation plays a crucial role in the progression from heart hypertrophy towards failure, establishing a clear association between MAO-induced ROS production, mitochondrial dysfunction, and cardiac failure, leading to propose MAO as a new promising therapeutic target in chronic diseases [3, 9, 15–20]. Here, MAOA is linked to heart failure.